Andrew Dahl's most recent trade in Donaldson Co. Inc. was a trade of 3,000 Common Stock done at an average price of $82.0 . Disclosure was reported to the exchange on Aug. 28, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Donaldson Co Inc | Andrew C. Dahlgren | President | Sale of securities on an exchange or to another person at price $ 81.96 per share. | 28 Aug 2025 | 3,000 | 7,504 (0%) | 0% | 82.0 | 245,880 | Common Stock |
| Donaldson Co Inc | Andrew C. Dahlgren | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Aug 2025 | 3,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Donaldson Co Inc | Andrew C. Dahlgren | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.00 per share. | 28 Aug 2025 | 3,000 | 10,504 (0%) | 0% | 28 | 84,000 | Common Stock |
| Edwards Lifesciences | Andrew M. Dahl | SVP, Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 5,670 | 5,670 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences | Andrew M. Dahl | SVP, Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 3,335 | 8,106 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences | Andrew M. Dahl | SVP, Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.30 per share. | 22 Feb 2025 | 176 | 4,684 (0%) | 0% | 73.3 | 12,901 | Common Stock |
| Syra Health Corp Ordinary | Andrew M. Dahlem | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2025 | 9,102 | 20,683 | - | - | Stock Options | |
| Syra Health Corp Ordinary | Andrew M. Dahlem | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Nov 2024 | 11,581 | 11,581 | - | - | Stock Options | |
| Donaldson Co Inc | Andrew C. Dahlgren | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 16,200 | 16,200 | - | - | Employee Stock Option (right to buy) | |
| Donaldson Co Inc | Andrew C. Dahlgren | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Sep 2024 | 3,355 | 9,155 (0%) | 0% | 0 | Common Stock | |
| Donaldson Co Inc | Andrew C. Dahlgren | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.82 per share. | 27 Sep 2024 | 1,651 | 7,504 (0%) | 0% | 73.8 | 121,877 | Common Stock |
| Edwards Lifesciences | Andrew M. Dahl | SVP, Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Sep 2024 | 2,920 | 4,690 (0%) | 0% | 0 | Common Stock | |
| Donaldson Co Inc | Andrew C. Dahlgren | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.78 per share. | 04 Mar 2024 | 2,500 | 7,778 (0%) | 0% | 38.8 | 96,950 | Common Stock |
| Donaldson Co Inc | Andrew C. Dahlgren | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2024 | 2,500 | 0 | - | - | Employee Stock Option (right to buy) | |
| Donaldson Co Inc | Andrew C. Dahlgren | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.52 per share. | 04 Mar 2024 | 1,978 | 5,800 (0%) | 0% | 72.5 | 143,445 | Common Stock |
| Donaldson Co Inc | Andrew C. Dahlgren | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.05 per share. | 10 Oct 2023 | 2,500 | 7,262 (0%) | 0% | 42.1 | 105,125 | Common Stock |
| Donaldson Co Inc | Andrew C. Dahlgren | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Oct 2023 | 2,500 | 0 | - | - | Employee Stock Option (right to buy) | |
| Donaldson Co Inc | Andrew C. Dahlgren | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.27 per share. | 10 Oct 2023 | 1,984 | 5,278 (0%) | 0% | 60.3 | 119,576 | Common Stock |
| Syra Health Corp Ordinary | Andrew M. Dahlem | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Oct 2023 | 10,000 | 10,000 | - | - | Stock Options | |
| Donaldson Co Inc | Andrew C. Dahlgren | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Sep 2023 | 17,200 | 17,200 | - | - | Employee Stock Option (right to buy) | |
| Donaldson Co Inc | Andrew C. Dahlgren | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Sep 2023 | 4,984 | 7,207 (0%) | 0% | 0 | Common Stock | |
| Donaldson Co Inc | Andrew C. Dahlgren | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.66 per share. | 21 Sep 2023 | 2,445 | 4,762 (0%) | 0% | 59.7 | 145,869 | Common Stock |
| Skillz Inc Ordinary Shares | Andrew Dahlinghaus | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2023 | 44,235 | 44,235 | - | - | Restricted Stock Units | |
| Donaldson Co Inc | Andrew C. Dahlgren | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2022 | 3,500 | 0 | - | - | Employee Stock Option (right to buy) | |
| Donaldson Co Inc | Andrew C. Dahlgren | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.58 per share. | 01 Dec 2022 | 3,500 | 4,650 (0%) | 0% | 33.6 | 117,530 | Common Stock |
| Donaldson Co Inc | Andrew C. Dahlgren | President | Sale of securities on an exchange or to another person at price $ 60.85 per share. | 01 Dec 2022 | 2,436 | 2,214 (0%) | 0% | 60.9 | 148,231 | Common Stock |
| Zivo Bioscience Inc | Andrew Dahl | Director, President / CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Oct 2021 | 376,000 | 376,000 | - | - | Nonstatutory Stock Option to Purchase Common Stock |